Search bioRxiv⌕ Search

Biology subjects

Vanaporn, M.

Publications and source records attributed to Vanaporn, M..

2 recordsLinked to original sources

Automating Candidate Gene Prioritization with Large Language Models: From Naive Scoring to Literature-Grounded Validation

BackgroundIdentifying promising therapeutic targets from thousands of genes in transcriptomic studies remains a major bottleneck in biomedical research. While large language models (LLMs) show potential for gene prioritization, they suffer from hallucination and lack systematic validation against expert knowledge. MethodsWe developed a two-stage computational framework that combines LLM-based screening with literature validation for systematic gene prioritization. Starting with 10,824 genes from the BloodGen3 repertoire, we applied multi-criteria evaluation for sepsis relevance, followed by retrieval-augmented generation (RAG) using 6,346 curated sepsis publications. A novel faithfulness evaluation system verified that LLM predictions aligned with retrieved literature evidence. ResultsThe framework identified 609 sepsis-relevant genes with >94% filtering efficiency, demonstrating strong enrichment for inflammatory pathways including TNF- signaling, complement activation, and interferon responses. Literature validation yielded 30 ultra-high confidence therapeutic candidates, including both established sepsis genes (IL10, TREM1, S100A9, NLRP3) and novel targets warranting investigation. Benchmark validation against expert-curated databases achieved 71.2% recall, with systematic correlation between computational confidence and evidence quality. The final candidate set balanced discovery (11 novel genes) with validation (19 known genes), maintaining biological coherence throughout the filtering process. ConclusionsThis framework demonstrates that rigorous methodology can transform unreliable LLM outputs into systematically validated biological insights. By combining computational efficiency with literature grounding, the approach provides a practical tool for prioritizing experimental validation efforts. The modular design enables adaptation to other diseases through knowledge base substitution, offering a systematic approach to literature-guided biomarker discovery. AvailabilitySource code and implementation details are available at https://github.com/taushifkhan/llm-geneprioritization-framework, vector database at https://doi.org/10.5281/zenodo.15802241 and Interactive demonstration at https://llm-geneprioritization.streamlit.app/

bioinformatics↗

Automating Candidate Gene Prioritization with Large Language Models: Development and Benchmarking of an API-Driven Workflow Leveraging GPT-4

In this exploratory study, we developed an automated workflow that leverages Large Language Models, specifically GPT-4, to prioritize candidate genes for targeted assay development. The workflow automates interaction with OpenAI models and enables prompt creation, submission. It features customizable prompts designed to evaluate candidate genes based on criteria such as association with biological processes, biomarker potential, and therapeutic implications, which can be tailored for specific diseases or processes. Benchmarking experiments comparing the performance of the Application Programming Interface (API)-based automated prompting approach with manual prompting demonstrated high consistency and reproducibility in gene prioritization results. The automated method exhibited scalability by successfully prioritizing genes relevant to sepsis from the BloodGen3 repertoire, comprising 11,465 genes, distributed among 382 modules. The workflow efficiently identified sepsis-associated genes across the repertoire, revealing distinct gene clusters and providing insights into their distribution within module aggregates and individual modules. This proof-of-concept study demonstrates how LLMs can enhance gene prioritization, streamlining the identification process for targeted assays across various biological contexts. However, it also reveals the need for further validation and highlights the exploratory nature of this work due to scoring inconsistencies and the necessity for manual fact-checking. Despite these challenges, the automated workflow holds promise for accelerating targeted assay development for disease management and paves the way for future research.

bioinformatics↗